SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Care-plan review) — Ray Charles — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientRay Charles
Date of birth1930-09-23
IdentifiersMRN HR-ML009-SYN-TD; SSN (made up) 000-09-5561
Document date1996-09-01
AuthorGloria Fenwick, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-month review with depression screening and the plan for any future pain. [S]

History of Present Illness

Mr. Charles returns six months after his first visit. He has had no opioid or other drug use and no cravings. His mood is good, and he answered the PHQ-9 aloud today with a score of 2, with no thoughts of suicide or self-harm. His eyes have been comfortable. He has had no falls. The naloxone sprays are in date. He finished the written plan for any future pain with Dr. Fenwick today and has it saved on his phone. [S]

ElementDetail
RecoverySustained remission; no cravings
MoodPHQ-9 2; item 9 scored 0
Pain planFinished and saved on his phone
FallsNone in six months

Review of Systems

SystemResultFinding
EyesNegativeNo eye pain, redness, or discharge
PsychiatricNegativeMood good; no cravings; no thoughts of suicide or self-harm; PHQ-9 score 2
MusculoskeletalNegativeNo falls or pain

3 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naloxone 4 mg nasal spray, one spray in one nostril for a suspected opioid overdose; may repeat every 2 to 3 minutes in alternating nostrilsOne spray (4 mg) in one nostril for suspected overdose; repeat every 2 to 3 minutes if there is no response, and call 911Nasal route1996-03-03activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1996-09-01Body height178cmS
1996-09-01Body weight80kgS
1996-09-01Body mass index (BMI) [Ratio]25.2kg/m2S
1996-09-01Systolic blood pressure128mm[Hg]S
1996-09-01Diastolic blood pressure76mm[Hg]S
1996-09-01Heart rate66/minS
1996-09-01Respiratory rate14/minS
1996-09-01Body temperature36.6CelS
1996-09-01Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1996-09-01Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S

Physical Exam

Vital signs recorded on 1996-09-01; see the Vital Signs section. [S]

SystemFinding
GeneralAlert, warm, and engaged
EyesNo light perception; lids and ocular surfaces quiet
PsychiatricEuthymic; organized thought; no signs of intoxication or withdrawal

Problems

ProblemClinical statusVerificationCodeProvenance
Blindness of both eyes since childhood, no light perception; cause never diagnosedactiveconfirmed H54.0X55S — Synthetic modern coding of the documented childhood blindness; category 5 (no light perception) is a synthetic grading of what the sources call blindness.
Opioid use disorder (heroin), in sustained remission for more than thirty years, without medication treatmentactiveconfirmed F11.21S — Synthetic modern coding of the publicly admitted heroin addiction and his documented recovery; listed as an active problem because it is managed at every visit, with remission carried by the code.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationEye comfort and ocular surface check: pain, redness, dischargeEvery visitCompleted todayNo pain, redness, or discharge
ExaminationTonometry (eye pressure)Every glaucoma visit; for blind eyes, only if pain or rednessNot indicatedPainless blind eyes, as advised by ophthalmology
ExaminationComprehensive eye examinationYearly for blind eyes, or with symptomsUp to dateOphthalmology examination five months ago; next in the spring
SurveyDepression screen (PHQ-9)At intake, at six months, and yearlyCompleted todayPHQ-9 2, read aloud, with item 9 scored 0
SurveySuicide-risk review and safety plan, with the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; the 988 Suicide & Crisis Lifeline still saved in his phone
Self-managementRecovery check: any return to use, cravings, triggers, and supportsEvery visitCompleted todayNo return to use and no cravings
Medication safetyNaloxone at home and when travelingAt intake; check expiry at each visitCompleted todayBoth sprays in date
SurveyDrug-use screen (DAST-10)YearlyUp to dateDAST-10 0 six months ago; next at the annual wellness visit
SurveyAlcohol screen (AUDIT-C)YearlyUp to dateAUDIT-C 2 six months ago; next at the annual wellness visit
LaboratoryHepatitis C, hepatitis B, and HIV testingAt entry to care for a person with a substance use disorderDueAt the annual wellness visit next month
Self-managementWritten plan for any future acute pain or surgeryBefore any planned procedure, and once in remissionCompleted todayFinished today and saved in an accessible format on his phone
Self-managementAccessible documents and communicationEvery visitCompleted todayPain plan and visit summary sent as accessible documents
Medication safetyMedicine labeling in braille or audioWith every new prescriptionUp to dateNo new prescriptions
ExaminationCDC STEADI fall-risk screenEvery visit from age 65Completed todayNo falls in six months
Self-managementAdvance care planningYearly from age 65DueAt the annual wellness visit next month
Self-managementVaccinationsYearly, per the CDC scheduleDueInfluenza and pneumococcal vaccines at the annual wellness visit next month

Goal progress:

Guideline basis: VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update (2020); Primary Open-Angle Glaucoma Preferred Practice Pattern (2025); Vision Rehabilitation Preferred Practice Pattern (2023); Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, glaucoma and depression, bipolar, and mood disorders monographs (2026)

Follow-up: Annual wellness visit in five weeks, with the hepatitis and HIV tests, vaccines, and advance care planning. Next scheduled visit 1996-10-06: subsequent annual wellness visit. [S]